Characteristics, prevalence and sources of stress in individuals who discontinue assisted reproductive technology treatments: a systematic review

被引:0
|
作者
Sousa, Elaine [1 ]
Nery, Simone F. [1 ]
Casalechi, Maira [1 ]
Thimoteo, Luiz C. [1 ]
Paiva, Sara P. C. [1 ]
Silva-Filho, Agnaldo L. [1 ]
Reis, Fernando M. [1 ]
机构
[1] Univ Fed Minas Gerais, Gynaecol Hosp Clin, Dept Obstet, Div Human Reprod, Ave Alfredo Balena, 110, 9 Andar, BR-30130100 Belo Horizonte, MG, Brazil
关键词
In-vitro fertilization; Discontinuation; Assisted reproductive technology; Stress; IN-VITRO FERTILIZATION; COUPLES DISCONTINUE; PREGNANCY RATES; FERTILITY; CARE; INFERTILITY; PROGRAM; CYCLES; BARRIERS; DECISION;
D O I
10.1016/j.rbmo.2023.01.020
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
By considering the reasons behind discontinuing assisted reproductive technology (ART) treatment, several studies have indicated that 'stress' is an important issue, but the prevalence of stressors and stress responses, either acute or chronic, remains unclear. In this systematic review, we evaluated the characteristics, prevalence and causes of what was perceived and reported as 'stress' by couples who discontinued ART treatment. Electronic databases were systematically searched, and studies were considered eligible if they evaluated stress as a possible reason for ART discontinuation. Twelve studies were included, with 15,264 participants from eight countries. In all studies, 'stress' was assessed through generic questionnaires or medical records, not by validated stress questionnaires or biomarkers. The prevalence of 'stress' ranged from 11-53%. When the results were pooled, 'stress' was cited as a reason for ART discontinuation by 775 out of 2507 participants (30.9%). Clinical factors associated with worse prognosis, physical discomfort due to treatment procedures, family demands, time pressure and economic burden were identified as sources of 'stress' that contributed to ART discontinuation. Precisely knowing the characteristics of the stress associated with infertility is essential to devise preventive or supportive interventions to help patients to cope and endure the treatments. Further studies are necessary to investigate whether the mitigation of stress factors can reduce ART discontinuation rates.
引用
收藏
页码:819 / 825
页数:7
相关论文
共 50 条
  • [31] Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis
    Goualou, Marianne
    Noumegni, Steve
    de Moreuil, Claire
    Le Guillou, Mathilde
    De Coninck, Gabrielle
    Hoffmann, Clement
    Robin, Sara
    Morcel, Karine
    Le Moigne, Emmanuelle
    Tremouilhac, Christophe
    Merviel, Philippe
    Le Mao, Raphael
    Leroyer, Christophe
    Bouee, Sarah
    Couturaud, Francis
    Tromeur, Cecile
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (03) : 283 - 294
  • [32] Management of Hydrosalpinx in the Era of Assisted Reproductive Technology: A Systematic Review and Meta-analysis
    Capmas, Perrine
    Suarthana, Eva
    Tulandi, Togas
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2021, 28 (03) : 418 - 441
  • [33] Risk of preeclampsia following assisted reproductive technology: systematic review and meta-analysis of 72 cohort studies
    Omani-Samani, Reza
    Alizadeh, Ahad
    Almasi-Hashiani, Amir
    Mohammadi, Maryam
    Maroufizadeh, Saman
    Navid, Behnaz
    Khedmati Morasae, Esmaeil
    Amini, Payam
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (16) : 2826 - 2840
  • [34] Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses
    Chih, Hui Ju
    Elias, Flavia T. S.
    Gaudet, Laura
    Velez, Maria P.
    BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
  • [35] Comparing infertility-related stress, coping, and quality of life among assisted reproductive technology and non-assisted reproductive technology treatments
    Swift, Alison
    Reis, Pamela
    Swanson, Melvin
    HUMAN FERTILITY, 2023, 26 (05) : 1248 - 1255
  • [36] Is there a relationship between assisted reproductive technology and maternal outcomes? A systematic review of cohort studies
    Heshmatnia, Fatemeh
    Jafari, Maryam
    Bozorgian, Leila
    Yadollahi, Parvin
    Khalajinia, Zohre
    Azizi, Marzieh
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2023, 21 (11) : 861 - 880
  • [37] Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review
    Njagi, Purity
    Groot, Wim
    Arsenijevic, Jelena
    Dyer, Silke
    Mburu, Gitau
    Kiarie, James
    HUMAN REPRODUCTION OPEN, 2023, 2023 (02)
  • [38] Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review
    Alviggi, Carlo
    Conforti, Alessandro
    Esteves, Sandro C.
    Andersen, Claus Yding
    Bosch, Ernesto
    Buehler, Klaus
    Ferraretti, Anna Pia
    De Placido, Giuseppe
    Mollo, Antonio
    Fischer, Robert
    Humaidan, Peter
    FERTILITY AND STERILITY, 2018, 109 (04) : 644 - 664
  • [39] Experiences of men undergoing assisted reproductive technology: A qualitative systematic review
    Hya, Kia Min
    Huang, Zhongwei
    Chua, Crystal Min Siu
    Shorey, Shefaly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 165 (01) : 9 - 21
  • [40] Effects of Growth Hormone Supplementation on Poor Ovarian Responders in Assisted Reproductive Technology: a Systematic Review and Meta-analysis
    Liu, Fen-Ting
    Hu, Kai-Lun
    Li, Rong
    REPRODUCTIVE SCIENCES, 2021, 28 (04) : 936 - 948